Literature DB >> 16092070

A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats.

Ragna Hussong1, Norbert Frank, Jutta Knauft, Carina Ittrich, Robert Owen, Hans Becker, Clarissa Gerhäuser.   

Abstract

Xanthohumol (XN) is a prenylated chalcone, which has been shown to possess a broad range of potential cancer preventive and additional biological activities. In the present study, we have determined the subchronic 4-wk toxicity of XN and monitored its influence on fertility and development of offspring in two fertility studies. Four-week-old female Sprague Dawley (SD) rats were treated with 0.5% XN in the diet or with 1,000 mg XN/kg body weight (b.w.) per day by gavage for 28 days. No remarkable treatment-related changes in general appearance and b.w. occurred during the study. After autopsy, liver, kidney, lung, heart, stomach, and spleen were examined macroscopically and histopathologically. Relative liver weights of animals in both treatment groups were significantly reduced by 30--40% in comparison with the control group, indicating weak hepatotoxicity. Also, mammary glands of treated rats appeared less developed compared to the controls. Consequently, we investigated the influence of XN on rat reproduction. In two fertility studies, XN (100 mg/kg b.w. per day), given either for 4 wk prior to or during mating, gestation, and nursing, did not cause any adverse effects on female reproduction and the development of offspring. Noteworthy, treatment of male rats prior to mating significantly (p=0.027) increased the sex ratio of male to female offspring. Overall, lifelong treatment at a daily dose of 100 mg/kg b.w. in a two-generation study did not affect the development of SD rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16092070     DOI: 10.1002/mnfr.200500089

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  12 in total

1.  Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Kwang S Ahn; Preetha Anand; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

2.  Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL/6J mice.

Authors:  Cristobal L Miranda; Valerie D Elias; Joshua J Hay; Jaewoo Choi; Ralph L Reed; Jan F Stevens
Journal:  Arch Biochem Biophys       Date:  2016-03-11       Impact factor: 4.013

3.  Effect of xanthohumol on melanogenesis in B16 melanoma cells.

Authors:  Jeung-Hyun Koo; Hyoung Tae Kim; Ha-Yong Yoon; Kang-Beom Kwon; Il-Whan Choi; Sung Hoo Jung; Han-Uk Kim; Byung-Hyun Park; Jin-Woo Park
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

4.  Xanthohumol impairs human prostate cancer cell growth and invasion and diminishes the incidence and progression of advanced tumors in TRAMP mice.

Authors:  Roberta Venè; Roberto Benelli; Simona Minghelli; Simonetta Astigiano; Francesca Tosetti; Nicoletta Ferrari
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

5.  Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice.

Authors:  Prakash Doddapattar; Branislav Radović; Jay V Patankar; Sascha Obrowsky; Katharina Jandl; Christoph Nusshold; Dagmar Kolb; Nemanja Vujić; Lalit Doshi; Prakash G Chandak; Madeleine Goeritzer; Helmut Ahammer; Gerald Hoefler; Wolfgang Sattler; Dagmar Kratky
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

6.  Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma.

Authors:  Selvi Kunnimalaiyaan; Kevin M Sokolowski; Mariappan Balamurugan; T Clark Gamblin; Muthusamy Kunnimalaiyaan
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  Xanthohumol induces growth inhibition and apoptosis in ca ski human cervical cancer cells.

Authors:  Wai Kuan Yong; Sri Nurestri Abd Malek
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-09       Impact factor: 2.629

8.  Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer.

Authors:  Kenta Saito; Yoichi Matsuo; Hiroyuki Imafuji; Tomotaka Okubo; Yuzo Maeda; Takafumi Sato; Tomoya Shamoto; Ken Tsuboi; Mamoru Morimoto; Hiroki Takahashi; Hideyuki Ishiguro; Shuji Takiguchi
Journal:  Cancer Sci       Date:  2017-12-03       Impact factor: 6.716

Review 9.  Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.).

Authors:  Chuan-Hao Jiang; Tao-Li Sun; Da-Xiong Xiang; Shan-Shan Wei; Wen-Qun Li
Journal:  Front Pharmacol       Date:  2018-05-22       Impact factor: 5.810

10.  Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines.

Authors:  Isabelle E Logan; Cristobal L Miranda; Malcolm B Lowry; Claudia S Maier; Jan F Stevens; Adrian F Gombart
Journal:  Int J Mol Sci       Date:  2019-03-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.